Abstract:
Background: Cervical cancer is the fourth most frequent cancer in women with an estimated 
570,000 new cases in 2018 representing 6.6% of all female cancers occurred in low and middle income countries. The prevalence of precancerous cervical lesion is not investigated before in 
Saint Peter Specialized Hospital.
Objectives: This study aimed to assess the magnitude of precancerous cervical lesions and associated 
factors among adult women with human immune deficiency virus on Anti Retroviral Therapy (ART) at 
Saint Peter Specialized Hospital, Addis Ababa, Ethiopia from November to July , 2020.
Methods and materials: A Hospital - based cross - sectional study. Data were collected using 
face-to-face interview and squamo-columnar junction was examined by inserting Un-lubricated 
bivalve speculum into the vagina and cervix and visualized with the help of halogen focus lamp. 
Visual inspection with acetic acid methos was used for precancerous cervical lesion screening. 
The collected data were entered into Epi-data version 3.1 and exported to Statistical Package for 
the Social Sciences (SPSS) version 24.0 for analysis. Binary logistic regression analysis were
used to identify factors associated with the precancerous cervical lesion. Statistical significance 
was considered at P-valve less than 0.05.
Results: A total of 267 women who were on ART were included in the study and the magnitude 
of precancerous cervical lesion was 7.5% with 95%CI 4.10%-10.5%. Modern family planning 
non-users (AOR=4.14; 95%CI=1.23-13.87), history of sexual transmission infection (STI) 
(AOR=5.39; 95% CI= 1.56-18.70) and high viral load (AOR=20.84; 95% CI= 6.18-70.25) had 
significant association with precancerous cervical lesion.
Conclusion: The magnitude of precancerous cervical lesion in the study area is relatively low 
compared to studies in low and middle income countries. Modern family planning , history of 
Sexual Transmitted Infection and viral load had a significant association with the precancerous 
cervical lesion.